GENEVA, Sept. 17 -- MODALIS THERAPEUTICS CORPORATION (3-11-5, Nihonbashi-Honcho, Chuo-ku, Tokyo1030023) filed a patent application (PCT/JP2025/008637) for "METHOD FOR TREATING MUSCULAR DYSTROPHY BY TARGETING LAMA1 GENE" on Mar 07, 2025. With publication no. WO/2025/187834, the details related to the patent application was published on Sep 11, 2025.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): YAMAGATA, Tetsuya (c/o Modalis Therapeutics Inc., 43 Foundry Avenue, Waltham, Massachusetts02453), QIN, Yuanbo (c/o Modalis Therapeutics Inc., 43 Foundry Avenue, Waltham, Massachusetts02453)
Abstract:
T...